NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/15/2025
Back to search
Official data from USPTO
ARTHRITIS THERAPY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ARTHRITIS THERAPY
ST13
US500000086423252Class
5
Filing
86423252
Registration
4714313
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
22
Latest update
08/16/2025
Trademark type
Word
Nice classes
5
Filing date
10/14/2014
Registration date
03/31/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/15/2025
Last transaction
08/16/2025
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
First use anywhere
08/08/2013
First use in commerce
08/08/2013
Drawing code
4
Owner type
03
Owner location
Reno, NV
Examiner
HESIK, APRIL
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
T.R.P. Company, Inc.
Representatives
John D. Long, Esq. LONG & CHYBIK
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Homeopathic pharmaceutical directed to address one or more symptoms of joint inflammation due to a breakdown of cartilage
Publications
History of USPTO decisions and trademark events.
22 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/15/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/15/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/14/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
03/31/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/31/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
07/26/2021
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
07/26/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/26/2021
ES8R
TEAS SECTION 8 RECEIVED
03/29/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/31/2020
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/31/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/25/2015
ALIE
ASSIGNED TO LIE
02/23/2015
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
02/02/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
02/02/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/02/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
02/02/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/02/2015
DOCK
ASSIGNED TO EXAMINER
01/27/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/21/2014
NWAP
NEW APPLICATION ENTERED
10/17/2014
Continuous trademark protection
Get notified about every new filing that threatens ARTHRITIS THERAPY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.